The Epoch Times spoke to Ross Kennedy, founder of Fortis Analysis, about his recent research concerning China-based company Fufeng Group Limited that's poised to set up shop in midwestern America. Fufeng is a manufacturer of bio-fermented products derived from corn, which are used in end products ranging from animal feed to pharmaceuticals. A Hong Kong-listed company, the group has multiple subsidiaries around the world, but most of its production facilities can be found in northeast China.

In early November, it was announced that Fufeng Group is in negotiations to bring its agribusiness company to Grand Forks, North Dakota. The new plant, which employs a manufacturing process revolving around the fermentation of corn starch, is expected to consume about 25 million bushels of corn a year. The cost of construction is estimated to near $350 million. Fufeng USA, the company's American subsidiary, is handling the new endeavor.